Strategic SBIR momentum Matregenix has secured multiple SBIR/STTR contracts with the U.S. Air Force and AFWERX, including Phase II and Direct-to-Phase II awards totaling several million dollars. This demonstrates strong government validation and a potential pathway for expanding defense and aerospace-related nanofiber solutions.

Defense and soft tissue opportunity Recent contracts focus on soft tissue repair nanofiber technologies for DoD programs, signaling a key cross-sell opportunity to adjacent defense agencies and civil-military medical programs seeking advanced biomaterials and tissue engineering solutions.

PFAS‑free PPE potential Partnerships aimed at developing PFAS-free active clothing and PPE indicate demand for safer, compliant protective gear. This can open sales avenues with civilian emergency responders, healthcare facilities, and industrial safety markets prioritizing sustainable, non-fluorinated textiles.

Facility scale and capacity Past facility expansions in Irvine and ongoing nanofiber manufacturing capabilities position Matregenix to support increased production for contract development and manufacturing services, enabling scalable partnerships with medium-to-large medical device or filtration companies.

Filtration and biomedical focus Core strengths in customizable nanofibrous materials for filtration and biomedical applications align with markets seeking advanced filtration media, medical devices, and implant coatings, presenting cross-sell opportunities with filtration manufacturers, wound care firms, and biomedical OEMs.